Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1948-7908
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry ; volume:4 ; number:1 ; day:31 ; month:1 ; year:2015 ; pages:55-63 ; date:3.2015
Journal of radiation oncology ; 4, Heft 1 (31.1.2015), 55-63, 3.2015
- Creator
-
Davis, Joanne N.
Medbery, Clinton
Sharma, Sanjeev
Perry, David
Pablo, John
D’Ambrosio, David J.
McKellar, Heidi
Kimsey, Frank C.
Chomiak, Paul N.
Mahadevan, Anand
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13566-014-0177-0
- URN
-
urn:nbn:de:101:1-2019102723572711727698
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Davis, Joanne N.
- Medbery, Clinton
- Sharma, Sanjeev
- Perry, David
- Pablo, John
- D’Ambrosio, David J.
- McKellar, Heidi
- Kimsey, Frank C.
- Chomiak, Paul N.
- Mahadevan, Anand
- SpringerLink (Online service)
Other Objects (12)
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study
Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Long-term survival and failure patterns in inoperable early-stage non-small cell lung cancer following stereotactic body radiotherapy: a single-institution retrospective study
Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience
Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study
Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Long-term survival and failure patterns in inoperable early-stage non-small cell lung cancer following stereotactic body radiotherapy: a single-institution retrospective study
Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience
Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study
Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Long-term survival and failure patterns in inoperable early-stage non-small cell lung cancer following stereotactic body radiotherapy: a single-institution retrospective study
Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience